N/A
Completed N=9
Designing an Implementation Strategy for Lung Screening and Smoking Cessation Treatment in Community Health Centers
Source: ClinicalTrials.gov NCT05447897 ↗Enrolled (actual)
9
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcomePrimary: Feasibility of Intervention Measure — 4 units on a scale
Summary
Tobacco use is the leading preventable cause of death in the US and a major driver of health disparities. Among our tools for reducing the harms of tobacco is lung cancer screening (LCS). This study will combine a review of existing qualitative and quantitative data on barriers to lung cancer screening and smoking cessation in underserved populations, a quantitative analysis of predictors of lung cancer screening and smoking cessation treatment use among Massachusetts Federally Qualified Health Centers (FQHC)s, and a stakeholder advisory group to synthesize these data and select implementation strategies that reflects the critical determinants and the strengths and resource constraints of the Federally Qualified Health Centers (FQHC) context.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of Intervention Measure |
4 | — |
| SECONDARY Acceptability of Intervention Measure |
4 | — |
| SECONDARY Intervention Appropriateness Measure |
4 | — |
Eligibility Criteria
Inclusion Criteria
FQHC implementation team including staff in the intervention FQHCs and their lung screening partners
Exclusion Criteria
FQHC staff or partners who leave the organization before end of study
Data sourced from ClinicalTrials.gov (NCT05447897). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.